miércoles, 20 de noviembre de 2013

Rare Disease Policy | www.eurordis.org

Rare Disease Policy | www.eurordis.org
NATIONAL PLANS

Towards comprehensive National Plans and Strategies for Rare Diseases across Europe

Upcoming EUROPLAN Conferences are taking place in Luxembourg on 19-20 November and Serbia
on 5-7 December

Rare Disease Policy

EURORDIS is at the centre of the regulatory process. Our contribution has been key in adopting important rare disease and orphan medicines legislation at the European level, such as the EU Regulation on Orphan Drugs, the EU Regulation on Paediatric Drugs, the EU Regulation on Advanced Therapies, the Commission Communication Rare Diseases: Europe's Challenges, the Council Recommendation on a European action in the field of rare diseases, the EU Directive on Patients’ Right to Cross-Border Healthcare, and more.
By partnering with national alliances for rare diseases in several countries, we also contribute to national processes, and facilitate the adoption and implementation of national plans or strategies for rare diseases in European countries.

Thanks to the EU Commission Communication and Council Recommendation on an action in the field of rare diseases, national rare diseases policies and plans have gained momentum.